脊柱转移瘤术后立体定向体部放疗共识指南:一项国际调查结果
OBJECTIVE Although postoperative stereotactic body radiation therapy (SBRT) for spinal metastases is increasingly performed, few guidelines exist for this application.…
要点
- 共识适应证:放射抵抗原发肿瘤、相邻1-2个椎体水平受累、既往放疗史。
- 共识禁忌证:超过3个连续椎体受累、ASIA A级、术后Bilsky 3级残留。
- 共识GTV为术后残留肿瘤,CTV为术前肿瘤范围及解剖间室加残留病变,不包含硬件和切口。
核心结论
- 脊柱放射外科专家共识认为,术后SBRT适用于放射抵抗原发肿瘤、病变局限于1-2个椎体水平和/或既往重叠放疗。
- GTV为术后残留肿瘤,CTV为术前肿瘤范围和解剖间室加残留病变,硬件和瘢痕不需纳入CTV。
- 未来研究对理解争议领域至关重要,包括是否需要环形治疗硬膜外间隙、椎旁延伸的管理及最佳剂量分割方案。
研究设计与样本
- 15名放射肿瘤科医生和5名神经外科医生,代表4个国家的19个中心,共完成1300余例术后脊柱SBRT,完成19项问卷调查。
- 共识定义:≥75%受访者选择为共识;≥50%选择为主要;无单一选项获多数为争议。
主要发现
- 共识适应证包括放射抵抗原发肿瘤、1-2个相邻椎体水平病变和既往放疗。
- 共识禁忌证包括超过3个连续椎体受累、ASIA A级(完全脊髓损伤无运动或感觉功能保留)和术后Bilsky 3级残留(脊髓受压且周围无脑脊液)。
- 治疗计划主要实践:术前MRI与术后T1加权MRI(伴或不伴钆)共注册,在T2加权MRI(和/或CT脊髓造影在明显硬件伪影时)上勾画脊髓。
- 共识GTV为基于MRI的术后残留肿瘤;主要CTV实践包括术后瘤床即术前肿瘤全程、相关解剖间室和任何残留病变;共识不将手术硬件和切口纳入CTV。
- PTV外扩存在争议,范围为0至2 mm;脊髓避让结构主要为真脊髓;环形治疗硬膜外间隙和椎旁延伸边缘存在争议。
关键数值与推荐
- 共识定义为≥75%受访者选择;主要定义为≥50%受访者选择;争议定义为无单一选项获多数。
- 共识适应证:放射抵抗原发肿瘤、1-2个相邻椎体水平病变、既往放疗。
- 共识禁忌证:超过3个连续椎体受累、ASIA A级、术后Bilsky 3级残留。
- 共识GTV为术后残留肿瘤;共识CTV不包括手术硬件和切口。
- PTV外扩范围0至2 mm为争议;处方剂量和脊髓耐受量存在争议,但给出了合理范围。
临床怎么用
- 术后SBRT可用于放射抵抗原发肿瘤、病变局限于1-2个椎体水平和/或既往重叠放疗的患者。
- 靶区勾画时GTV取术后残留肿瘤,CTV包括术前肿瘤全程和解剖间室加残留病变,不包含硬件和瘢痕。
- 治疗计划中应共注册术前MRI与术后T1加权MRI,并在T2加权MRI或CT脊髓造影上勾画脊髓。
- 作者认为未来研究对理解争议领域至关重要,包括环形治疗硬膜外间隙的必要性、椎旁延伸管理和最佳剂量分割方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Although postoperative stereotactic body radiation therapy (SBRT) for spinal metastases is increasingly performed, few guidelines exist for this application. The purpose of this study is to develop consensus guidelines to promote safe and effective treatment for patients with spinal metastases. METHODS Fifteen radiation oncologists and 5 neurosurgeons, representing 19 centers in 4 countries and having a collective experience of more than 1300 postoperative spine SBRT cases, completed a 19-question survey about postoperative spine SBRT practice. Responses were defined as follows: 1) consensus: selected by ≥ 75% of respondents; 2) predominant: selected by 50% of respondents or more; and 3) controversial: no single response selected by a majority of respondents. RESULTS Consensus treatment indications included: radioresistant primary, 1-2 levels of adjacent disease, and previous radiation therapy. Contraindications included: involvement of more than 3 contiguous vertebral bodies, ASIA Grade A status (complete spinal cord injury without preservation of motor or sensory function), and postoperative Bilsky Grade 3 residual (cord compression without any CSF around the cord). For treatment planning, co-registration of the preoperative MRI and postoperative T1-weighted MRI (with or without gadolinium) and delineation of the cord on the T2-weighted MRI (and/or CT myelogram in cases of significant hardware artifact) were predominant. Consensus GTV (gross tumor volume) was the postoperative residual tumor based on MRI. Predominant CTV (clinical tumor volume) practice was to include the postoperative bed defined as the entire extent of preoperative tumor, the relevant anatomical compartment and any residual disease. Consensus was achieved with respect to not including the surgical hardware and incision in the CTV. PTV (planning tumor volume) expansion was controversial, ranging from 0 to 2 mm. The spinal cord avoidance structure was predominantly the true cord. Circumferential treatment of the epidural space and margin for paraspinal extension was controversial. Prescription doses and spinal cord tolerances based on clinical scenario, neurological compromise, and prior overlapping treatments were controversial, but reasonable ranges are presented. Fifty percent of those surveyed practiced an integrated boost to areas of residual tumor and density override for hardware within the beam path. Acceptable PTV coverage was controversial, but consensus was achieved with respect to compromising coverage to meet cord constraint and fractionation to improve coverage while meeting cord constraint. CONCLUSIONS The consensus by spinal radiosurgery experts suggests that postoperative SBRT is indicated for radioresistant primary lesions, disease confined to 1-2 vertebral levels, and/or prior overlapping radiotherapy. The GTV is the postoperative residual tumor, and the CTV is the postoperative bed defined as the entire extent of preoperative tumor and anatomical compartment plus residual disease. Hardware and scar do not need to be included in CTV. While predominant agreement was reached about treatment planning and definition of organs at risk, future investigation will be critical in better understanding areas of controversy, including whether circumferential treatment of the epidural space is necessary, management of paraspinal extension, and the optimal dose fractionation schedules.
引用
- Redmond KJ, Lo SS, Soltys SG, et al. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J Neurosurg Spine. 2016. PMID: 27834628. doi:10.3171/2016.8.SPINE16121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。